Condensed consolidated statements of stockholders’ (deficit) equity - USD ($) $ in Thousands	Total		Previously Reported	Revision of Prior Period, Adjustment	Non-redeemable convertible preferred stock		Non-redeemable convertible preferred stock Previously Reported	Non-redeemable convertible preferred stock Revision of Prior Period, Adjustment	Common stock		Common stock Previously Reported	Common stock Revision of Prior Period, Adjustment	Additional paid-in capital		Additional paid-in capital Previously Reported	Additional paid-in capital Revision of Prior Period, Adjustment	Accumulated deficit		Accumulated deficit Previously Reported	Accumulated deficit Revision of Prior Period, Adjustment	Accumulated other comprehensive loss		Accumulated other comprehensive loss Previously Reported	Accumulated other comprehensive loss Revision of Prior Period, Adjustment
Preferred stock, balance (in shares) at Dec. 31, 2021					122,564,333	[1]	137,765,828	(15,201,495)
Common stock, balance (in shares) at Dec. 31, 2021									2,817,498	[1]	3,166,949	(349,451)
Balance at Dec. 31, 2021	$ 3,020	[1]	$ 3,020	$ 0	$ 189,881	[1]	$ 189,881	$ 0	$ 0	[1]	$ 2,610	$ (2,610)	$ 148,850	[1]	$ 146,240	$ 2,610	$ (325,268)	[1]	$ (325,268)	$ 0	$ (10,443)	[1]	$ (10,443)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)									8,768
Exercise of stock options	7												7
Stock-based compensation	783												783
Foreign currency translation adjustment, net of tax	(70)																				(70)
Net loss	(11,657)																(11,657)
Preferred stock, balance (in shares) at Mar. 31, 2022					122,564,333
Common stock, balance (in shares) at Mar. 31, 2022									2,826,266
Balance at Mar. 31, 2022	$ (7,917)				$ 189,881				$ 0				149,640				(336,925)				(10,513)
Common stock, balance (in shares) at Dec. 31, 2022	113,335,530								113,335,530
Balance at Dec. 31, 2022	$ (5,914)								$ 11				381,274				(376,797)				(10,402)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	672,583								598,368
Exercise of stock options	$ 546												546
Issuance of common stock in connection with the Purchase Agreement (in shares)									13,239,654
Issuance of common stock in connection with the Purchase Agreement	15,683								$ 1				15,682
Stock-based compensation	6,755												6,755
Short swing profit settlement	244												244
Foreign currency translation adjustment, net of tax	(19)																				(19)
Net loss	$ (24,608)																(24,608)
Common stock, balance (in shares) at Mar. 31, 2023	127,173,552								127,173,552
Balance at Mar. 31, 2023	$ (7,313)								$ 12				$ 404,501				$ (401,405)				$ (10,421)

[1] Shares of legacy non-redeemable convertible preferred stock and legacy common stock have been retroactively restated to give effect to the Merger.